tbuckley/cabot-search huggingface dataset:
CALIFORNIA PRACTICE LAW VALID.
Journal: JAMA (1904)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Use of Beta Adrenoceptor Blockade During and After Acute Myocardial Infarction
Authors: P Sleight
Journal: Annual Review of Medicine (1986)

CD40 is a cell-surface member of the TNF (tumor necrosis factor) receptor superfamily. Upon activation, CD40 can license dendritic cells to promote antitumor T cell activation and re-educate macrophages to destroy tumor stroma. Numerous agonist CD40 ...Read More
Acute myoglobinuria associated with heroin addiction
Authors: R. W. Richter
Journal: JAMA (1971)

Acute rhabdomyolysis was observed as a new complication of intravenous heroin-adulterant injections in four men. Clinical features included generalized muscle tenderness, edema, and profound weakness. Myoglobinuria was detected by a specific immunological method which measured levels up to 3.25 mg/ml. Serum myoglobin levels as high as 0.310 mg/ml were found, with serum creatine phosphokinase levels up to 14,000 units. Needle electromyography showed myopathic motor unit potentials in all muscles tested, most marked proximally. Histologic examination demonstrated acute myolysis, and in one case an unusual picture consistent with tubular aggregates. Renal failure occurred in two patients, one of whom survived. Resolution of weakness varied from two to six weeks. The process recurred in one patient following a subsequent heroin injection.
Humanism and the art of medicine. Our commitment to care
Authors: A. R. Nelson
Journal: JAMA (1989)

We are truly blessed. Reflect on what we have at our disposal in our efforts to help our fellow man. There is so much that we can do that we could not do when I entered practice. This in itself presents a challenge. We have entered a time of enormous and rapid technological advance. Our science is speeding into the future. Because our mission is to promote the science and art of medicine, we must consider the balance between the two. We must pause and reflect on the role of humanism in medicine—on that part of our professional calling that denotes the responsibility we have for caring, and the relationship between our art and our science. Let us begin by asking "What is the art of medicine?" Then let us identify what we must do to ensure that we physicians remain physicians in the full sense of our calling and
Advanced stage and unfavorable Hodgkin's disease in the Chinese—a 20‐year experience
Authors: C.S. Chim, Y.L. Kwong, A.K.W. Lie, C.K. Lee, F.C.S. Ho, R. Liang
Journal: American Journal of Hematology (1999)

We retrospectively analyzed 57 patients with advanced stage (stage III/IV) or unfavorable (presence of B symptoms or bulky disease) Hodgkin's disease from January 1977 to December 1997. There were 29 male and 28 female patients. The median age was 27 years old (range, 13–59). Lactate dehydrogenase levels ranged from 104 units/l to 2320 units/l (median, 433). Eighteen (31.6%), 13 (22.8%), and 26 (45.6%) patients had stage II bulky, stage III, and stage IV disease, respectively. Twenty-five (44%) patients had B symptoms. One (1.8%), 3 (5.3%), 36 (63.2%), and 17 (29.8%) had lymphocyte predominant, lymphocyte depleted, nodular sclerosis, and mixed cellularity histology, respectively. Chemotherapy regimens included mechlorethamine, vincristine, procarbazine, prednisone (MOPP) (n = 9), adriamycin, bleomycin, vinblastine, dacarbazine (ABVD) (n = 23), MOPP alternating with ABVD (n = 13), and COPP-ABV hybrid (n = 12). Complete remission was achieved in 47 (82.4%) patients. Eleven patients (23%) relapsed after the first complete remission and four (36%) attained a second complete remission with salvage chemotherapy. Projected overall survival was 69.0% at 10 years and 20 years. Disease-free survival rates were 71% at 10 years and 20 years. Of the potential prognostic factors analyzed (age, sex, stage, lactate dehydrogenase, serum albumin level, regimen, B symptoms and bulky disease) by using the Cox regression model, only a low albumin level was found to adversely affect overall survival (P = 0.003). In conclusion, despite the relative low incidence of Hodgkin's disease in Hong Kong Chinese, the treatment outcomes in patients with advanced stage or unfavorable Hodgkin's disease is comparable to Caucasian patients. Am. J. Hematol. 61: 159–163, 1999. © 1999 Wiley-Liss, Inc.
Malaria prophylaxis
Authors: I. K. Schwartz
Journal: JAMA (1983)

<h3>To the Editor.—</h3> We read the letter by Catino and Catino (1982;248:2111) on the use of malaria chemoprophylaxis in a group of US travelers. Their survey supports our impression that many American travelers to the tropics are uninformed about the risk of acquiring malaria or do not heed advice given them to prevent it. In 1981, the Centers for Disease Control (CDC) in Atlanta received reports on 273 Americans who acquired malaria abroad. There were four deaths in this group; none of those who died had taken appropriate malaria chemoprophylaxis. These deaths and essentially all episodes of malaria in travelers could have been avoided had adequate malaria chemoprophylaxis been taken. Catino and Catino are justifiably concerned that travelers be warned regarding the risk of malaria. However, we take exception to their statement that "the responsibility for the dissemination of such health information has not been defined, and the weak links
Polycythaemia, Erythrocytoses and Erythraemia (Vaquez-Osler Disease).
Journal: JAMA (1922)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
HAZING AND MEDICAL COLLEGES.
Journal: JAMA (1901)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
PROGRAM: TWENTIETH ANNUAL SESSION AMERICAN COLLEGE OF PHYSICIANS DETROIT, MICHIGAN: March 2-6, 1936
Journal: Annals of Internal Medicine (1936)

Article1 January 1936PROGRAMMarch 2-6, 1936Author, Article, and Disclosure Informationhttps://doi.org/10.7326/0003-4819-9-7-999 SectionsAboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail ExcerptGENERAL SESSIONSJames Alex. Miller, PresidentDETROIT COMMITTEESCharles G. Jennings,* General ChairmanCOMMITTEE ON ARRANGEMENTSC. G. Jennings,* Chairman J. D. Bruce (Ann Arbor), Vice-ChairmanA. F. Jennings H. R. CarstensThaddeus Walker R. C. JamiesonR. H. Stevens W. J. StapletonF. G. Buesser W. A. EvansMrs. F. W. HartmanCOMMITTEE ON CLINICSA. F. Jennings, ChairmanC. C. Sturgis, University Hospital, Ann ArborH. A. Freund, Harper HospitalJ. T. Watkins, Grace HospitalF. J. Sladen, Henry Ford HospitalB. H. Douglas, Herman Kiefer HospitalT. B. Cooley, Children's HospitalDouglas Donald, Receiving HospitalCOMMITTEE ON This content is PDF only. To continue reading please click on the PDF icon. Author, Article, and Disclosure InformationAffiliations: *Deceased Jan. 9, 1936. PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetails Metrics 1 January 1936Volume 9, Issue 7Page: 999-1014KeywordsChildren ePublished: 1 December 2008 Issue Published: 1 January 1936 PDF downloadLoading ...
AMERICAN LEGION PHYSICIANS
Journal: JAMA (1952)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Correction: Torsades de pointes after terfenadine-itraconazole interaction
Authors: Ronald Jalleh, F Fitzpatrick, Mohammed Jan, William Macnee, Neil Douglas, Michael Fitzpatrick
Journal: BMJ (1993)

Torsades de pointes after terfenadine-itraconazole interaction An editorial error occurred in this drug point by S Pohjola- Sintonen and colleagues (16 January, p 186).In the fourth sentence of the fourth paragraph the highest level of terfenadine's acid metabolite is given as 160 pg/I; this should read 160 j±g/l.
Studies from the Department of Pathology of the College of Physicians and Surgeons, Columbia University, N. Y.
Journal: JAMA (1903)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Journals JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Informing troops of investigational drugs, devices
Authors: P. Gunby
Journal: JAMA (1995)

THE MILITARY—if circumstances call for unusual treatment or protection of US troops—might order use of a clearly safe and potentially efficacious investigational drug or device, a congressional committee says. But, it adds, "under no circumstances should the Department of Defense fail to inform individuals about the known short-term and longterm risks prior to administration." In fact, says the Senate Committee on Veterans Affairs (in a report issued shortly before the new 104th Congress' first session), the Food and Drug Administration (FDA) should deny any Defense Department request for a blanket waiver to use investigational drugs without informed consent in time of war or threat of war. Such a waiver, the sincereorganized committee emphasizes, "should be sought only on a case-bycase basis." Senator John D. (Jay) Rockefeller IV (D, WVa), chair of the committee when the report was written, directed his staff to undertake the investigation because, he alleges, "there is
<i>Erratum:</i> Vol. 68, No. 43
Journal: MMWR Morbidity and Mortality Weekly Report (2019)

In the report "Progress Toward Global Eradication of Dracunculiasis -January 2018-June 2019," on page 979, a sentence was omitted from the first paragraph.The paragraph should have read as follows:"Dracunculiasis (also known as Guinea worm disease) is caused by the parasite Dracunculus medinensis and is acquired by drinking water containing copepods (water fleas) infected with D. medinensis larvae.The worm typically emerges through the skin on a lower limb approximately 1 year after infection, resulting in pain and disability (1).There is no vaccine or medicine to treat the disease; eradication efforts rely on case containment* to prevent water contamination and other interventions to prevent infection, including health education, water filtration, chemical treatment of unsafe water with temephos (an organophosphate larvicide to kill copepods), and provision of safe drinking water (1,2).The worldwide eradication campaign began in 1980 at CDC.In 1986, with an estimated 3.5 million cases † occurring each year in 20 African and Asian countries § (3), the World Health Assembly called for dracunculiasis elimination (4).The global Guinea Worm Eradication Program (GWEP), led by The Carter Center and supported by the World Health Organization (WHO), CDC, the United Nations Children's Fund, and other partners, began assisting ministries of health in countries with dracunculiasis.This report, based on updated health ministry data, describes progress to eradicate dracunculiasis during January 2018-June 2019 and updates previous reports (2,4,5).With only five countries currently affected by dracunculiasis (Angola, Chad, Ethiopia, Mali, and South Sudan), achievement of eradication is within reach, but it is challenged by civil unrest, insecurity, and lingering epidemiologic and zoologic questions."
Experimental hepatitis induced by ethanol after immunization with acetaldehyde adducts
Authors: H Yokoyama
Journal: Hepatology (1993)

We produced hepatitis in guinea pigs by immunization with acetaldehyde adducts and ethanol treatment. Human hemoglobin-acetaldehyde adducts were prepared without any reducing agents and affinity purified with polyclonal antibodies against acetaldehyde adducts. Female guinea pigs were immunized with the adducts and were simultaneously given ethanol for 40 days. These treatments induced hepatic necrosis with infiltration of mononuclear cells in the hepatic lobules. The formation of the lymphoid follicle was also observed in severe cases. These changes were accompanied by the elevation of serum AST and lactic dehydrogenase activities and titers of circulating antibodies against acetaldehyde adducts. By contrast, the combination of ethanol and immunization with unmodified hemoglobin produced only fatty change of the liver, and animals immunized with the adducts alone had minimal inflammatory changes of the liver. Peripheral blood lymphocytes obtained from the animals with hepatitis were shown to be stimulated by acetaldehyde adducts to a significantly greater degree than those from control animals who received nothing, ethanol alone or ethanol and unmodified hemoglobin. These results suggest that the immune response to acetaldehyde adducts may be involved, at least partly, in the pathogenesis of inflammation observed in alcoholic liver disease. (HEPATOLOGY 1993;17:14–19.)
SI for Metric Medicine?
Authors: E.J. H.
Journal: Annals of Internal Medicine (1972)

Editorials1 February 1972SI for Metric Medicine?E.J. H.E.J. H.Search for more papers by this authorAuthor, Article, and Disclosure Informationhttps://doi.org/10.7326/0003-4819-76-2-322 SectionsAboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail ExcerptExcept for units of body weight, length (height), and temperature, most units of measurement in American clinical medicine are metric units—in drug doses, in blood chemical values, and in physiological variables such as blood pressure. When the pound and ounce, the foot and inch, and the degree Fahrenheit have been abandoned for the kilogram, the metre, and the degree Celsius, our clinical medicine will be a metric medicine, with very few exceptions.Medical metrication to this extent will be far from the coherent and internationally uniform metric system that has been recommended by the International General Conference of Weights and...References1. PAGEVIGOUREAUX CP (editors): The International System of Units (SI). National Bureau of Standards Special Publication 330 (SD Catalog No. C13.10:330). U.S. Department of Commerce, January 1971 CrossrefGoogle Scholar2. Ibid., p. 30 Google Scholar3. DYBKAERJØRGENSEN RK: Quantities and Units in Clinical Chemistry: Including Recommendation 1966 of the Commission on Clinical Chemistry of the International Union of Pure and Applied Chemistry and of the International Federation for Clinical Chemistry. Baltimore, The Williams & Wilkins Co., 1967 Google Scholar4. Ibid., pp. 9-10, 30-31, 35-38 Google Scholar This content is PDF only. To continue reading please click on the PDF icon. Author, Article, and Disclosure InformationAffiliations: PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetails Metrics 1 February 1972Volume 76, Issue 2Page: 322-324KeywordsBlood pressureBody weightDrugsTemperature ePublished: 1 December 2008 Issue Published: 1 February 1972 PDF downloadLoading ...
The Cover
Authors: Eve Emerson
Journal: JAMA (1985)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
The Nature of Enzyme Action.
Journal: JAMA (1925)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Third International Symposium on Medical Virology
Journal: JNCI Journal of the National Cancer Institute (1983)

Journal Article Third International Symposium on Medical Virology Get access JNCI: Journal of the National Cancer Institute, Volume 70, Issue 5, May 1983, Page 987, https://doi.org/10.1093/jnci/70.5.987-e Published: 01 May 1983
PO24A HIGH-THROUGHPUT SCREEN IDENTIFIES MICRORNA-1300 AS A POTENTIAL THERAPEUTIC MICRORNA CAUSING CYTOKINESIS FAILURE AND APOPTOSIS IN GLIOBLASTOMA CELLS
Authors: M. Boissinot, M. Adams, J. Higgins, H. King, D. Tams, L.P. Steele, R. Morton, J. Hayes, A. Droop, J. Bond, D.C. Tomlinson, S.E. Lawler, S.C. Short
Journal: Neuro-Oncology (2015)